Defining DSCSA Trading Partners
Today FDA issued draft DSCSA compliance guidance on how to identify DSCSA Trading Partners. This draft guidance provides clarity on how to classify trading partner
August 21, 2017
July 7, 2017
Unmarked Product to Become Risky
One Year Enforcement Delay – Not!? Hidden Timetable in DSCSA Product Identifier Requirements With about 100 working days left until the November 27, 2017 deadline
June 30, 2017
FDA Proposes 1 Year Enforcement Delay
Product Identifier Requirements would take effect no later than November 27, 2018 June 30, 2017 FDA issues a draft DSCSA compliance guidance delaying enforcement action
November 12, 2015
Interoperability Enables Traceability
Understand the Challenges and Opportunities Pharmaceutical traceability is the new regulatory reality. Within the next five years, most markets will mandate pharmaceutical serialization at the
June 2, 2015
FDA warns Doctors about Risks of Purchasing Unsafe Medications
As of January 1, 2015 the DSCSA mandated that all healthcare practitioners who dispense or administer prescription drugs to patients must purchase their prescription drug
